---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-22-019051"
form_type: "8-K"
ticker: "GLSI"
cik: "0001799788"
company_name: "Greenwich LifeSciences, Inc."
filed_at: "2022-07-12T23:59:59+00:00"
generated_at: "2026-06-24T16:54:21.549277+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Greenwich LifeSciences enters $100M ATM equity offering agreement with Jefferies

## Summary
- Entered Open Market Sale Agreement with Jefferies LLC for at-the-market offering of common stock up to $100M.
- Commission rate of up to 3.0% of gross proceeds; Jefferies gets customary indemnification.
- Proceeds intended for general corporate purposes including GP2 clinical development, R&D, working capital.
- No obligation to sell any shares; company can suspend offering.

## SEC filing metadata
- accession: 0001493152-22-019051
- form_type: 8-K
- ticker: GLSI
- cik: 0001799788
- company_name: Greenwich LifeSciences, Inc.
- filed_at: 2022-07-12T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 1.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1799788/000149315222019051/0001493152-22-019051-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1799788/000149315222019051/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-22-019051
- JSON: https://secwatch.observer/filing/0001493152-22-019051.json
- Plain text: https://secwatch.observer/filing/0001493152-22-019051.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.